No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50070 |
Balb/3T3-A31-1-1 |
mouse |
embryo, whole |
fibroblast, subclone of Balb/3T3-A31-1, (Strain problem was found. Refer Important Notice at cell detail page.) |
|
2 | general cells |
IFO50477 |
FS-1 |
human |
bone marrow stroma |
This cell line produces IL-6 and SCF into its supernatant. Although this cell line was reported as immortalized cell line, the ampoules preserved in the cell bank hardly proliferated. |
|
3 | general cells |
JCRB0143.2 |
F2408 EBNA2 cl-16 |
rat |
whole body of embryo |
F2408 cell line transfected with recombinant plasmid pZE2 with coding region of the EBNA2 and the expression of the EBNA2 was strong in this strain. |
|
4 | general cells |
JCRB0267 |
PC12MS |
rat |
chromaffin cell |
Moderately NGF sensitive clone of rat PC12 cell line. |
|
5 | general cells |
JCRB0618.1 |
TGW.P3 |
human |
adrenal grand |
Serum free cell culture of the human neuroblastoma cell line, TGW. |
|
6 | general cells |
JCRB0833 |
NH-12 |
human |
adrenal gland |
neuroblastoma, adrenal gland |
|
7 | general cells |
JCRB1006.6 |
OUMS-36T-6 |
human |
embryo |
hTRT gene transfected normal human embryo fibroblast cell line. |
|
8 | general cells |
JCRB1020 |
RERF-LC-Ad1 |
human |
lung |
Human lung cancer cell line, adenocarcinoma. |
|
9 | general cells |
JCRB1066 |
KMH-2 |
human |
cervical tumor |
Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis. |
|
10 | general cells |
JCRB1370 |
TAS-5 |
mouse x rat |
|
Hybridoma cell line producing antibody against mouse CD49d (VLA-4 a chain). Binding inhibition VLA-4/VCAM-1 and VLA-4/Fibronectin |
|
11 | general cells |
JCRB1442 |
ASF-4-4L2 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
|
12 | genetically-modified cells |
JCRB1459 |
HUEhT-2 |
human |
human umbilical vein |
Immortalized human umbilical vein endothelial cell line established (HUVEC) by electroporation of pIRES-hTERT-hygr. |
|
13 | genetically-modified cells |
JCRB1490 |
POLZ L2618M |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) |
|
14 | immortalized mesenchymal stem cell |
JCRB1546 |
UCB408E7-TERT34 |
human |
umbilical cord blood |
Immortalized human umbilical cord blood-derived mesenchymal stem cells. |
|
15 | general cells |
JCRB1599 |
hTf30-8H |
mouse x mouse |
|
This cell line produce monoclonal antibody against human transferrin. |
|
16 | general cells |
JCRB1631.01 |
hTf/CHO-S #29/sf |
hamster, Chinese |
ovary |
This cell line produce human transferrin (cell freezed by Cryoprotective Medium). |
|
17 | general cells |
JCRB1747 |
XYFMGC50H |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
18 | general cells |
JCRB1810 |
MOLM-13 |
human |
|
Human acute monocytic leukemia (AML-M5a) cell line. MOLM-13 was established from the same donor as MOLM-14. |
|
19 | genetically-modified cells |
JCRB1975 |
MDCK-dHBEGF-EKARrEV-NLS |
dog |
kidney |
heparin-binding EGF (HBEGF)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.